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Abstract
Purpose: To create a clinically viable dose-volume histogram (DVH) estimation model using the Varian
RapidPlan (Varian Medical Systems, Palo Alto USA) knowledge based planning (KBP) platform. This
model aims to evaluate locally advanced rectal cancer with 6X IMRT, and was developed on a plan
database taken from the RTOG 0822 national clinical trial. This is the first multi-institutional 6X IMRT dose
estimation model designed using RapidPlan. The effectiveness of the model as a dosimetry quality
assurance (QA) tool was evaluated.
Methods: Treatment plans submitted to the RTOG 0822 clinical trial were dosimetrically evaluated for
plan quality. Plans whose DVH statistics met RTOG 0822 target criteria were identified as high-quality, and
were used in the initial training sample for the model. Of the 97 IMRT plans enrolled in the trial, 58 were
treated with only 6X photons, and 26 of those were identified as high-quality plans. All 6X enrolled plans
were iteratively re-optimized with the model to test clinical effectiveness, evaluate the model as a tool for
treatment planning QA, and continuously expand the model’s training sample. Re-optimized plans which
met target criteria were added to the training sample, resulting in a total of 40 geometries in the training
sample.
Results: The rectal IMRT RapidPlan model created in this paper was shown to accurately predict
estimated DVH bands for all viable high-quality plans enrolled in the clinical trial. The model was also able
improve the DVH statistics for a significant majority of the low-quality plans enrolled in the clinical trial.
Conclusion: The RapidPlan rectal 6X IMRT model created in this study can be used as an effective tool for
dosimetry QA and initial plan creation.
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Abstract
Purpose: To create a clinically viable dose-volume histogram (DVH) estimation model using the
Varian RapidPlan (Varian Medical Systems, Palo Alto USA) knowledge based planning (KBP)
platform. This model aims to evaluate locally advanced rectal cancer with 6X IMRT, and was
developed on a plan database taken from the RTOG 0822 national clinical trial. This is the first
multi-institutional 6X IMRT dose estimation model designed using RapidPlan. The
effectiveness of the model as a dosimetry quality assurance (QA) tool was evaluated.
Methods: Treatment plans submitted to the RTOG 0822 clinical trial were dosimetrically
evaluated for plan quality. Plans whose DVH statistics met RTOG 0822 target criteria were
identified as high-quality, and were used in the initial training sample for the model. Of the 97
IMRT plans enrolled in the trial, 58 were treated with only 6X photons, and 26 of those were
identified as high-quality plans. All 6X enrolled plans were iteratively re-optimized with the
model to test clinical effectiveness, evaluate the model as a tool for treatment planning QA, and
continuously expand the model’s training sample. Re-optimized plans which met target criteria
were added to the training sample, resulting in a total of 40 geometries in the training sample.
Results: The rectal IMRT RapidPlan model created in this paper was shown to accurately
predict estimated DVH bands for all viable high-quality plans enrolled in the clinical trial. The
model was also able improve the DVH statistics for a significant majority of the low-quality
plans enrolled in the clinical trial.
Conclusion: The RapidPlan rectal 6X IMRT model created in this study can be used as an
effective tool for dosimetry QA and initial plan creation.
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software that is easily integrated with the Aria
record and verify system (RVS) and the Eclipse
treatment planning system (TPS).
KBP
programs are designed to learn what dose
distributions are achievable by studying a
submitted set of high-quality treatment plans in
order to predict an optimized DVH for any
given patient with a similar tumor. When a
treatment plan is submitted to the KBP as
learning material, the KBP correlates the treated
gantry angles and patient geometry (input) with
the DVH statistics to the segmented organs
(output). Principal Component Analysis (PCA)
is used to characterize the most salient features
of the patient anatomy, and these features are
correlated with segmented organ DVH via
Support Vector Regression (SVR) [8].
Once these correlations are calculated, the
KBP model has effectively learned from its
library, and can produce DVH estimations with
consistently good optimality [9]. Despite these
benefits and ease of use, KBP’s such as
RapidPlan inextricably need a large library of
high-quality plans to produce well-trained
models. While this can be a challenge for new
or smaller clinics with a limited patient backlog,
this need produces renewed opportunities to
utilize the data submitted to massive clinical
trials, such as the RTOG. Data suggests that
compliance with RTOG criteria is associated
with increased survival rates, so it is suggested
that the library for a given RapidPlan model is
created from plans that meet these criteria [10].
RTOG 0822 is a phase II clinical trial that
studied the decrease in gastrointestinal toxicity
when IMRT is used for preoperative
chemoradiotherapy as compared to traditional
3DCRT, as studied in RTOG 0247 [11].
Clinical plans enrolled in this trial treated 45 Gy
IMRT to the rectum and draining lymphatics at
risk followed by a 5.4 Gy 3DCRT boost at 1.8
Gy daily fractions. The study closed December
2016 with 79 patients accrued with a total 97
therapy plans [12]. It should be noted that only
the 6X IMRT plans submitted to this study were
used in RapidPlan model created in this paper.

1 Introduction
Colorectal cancer is the third most commonly
diagnosed cancer among the worldwide
populace, ranking in as the second most
common cancer for women and the third most
common cancer for men. While the current
mortality rate for colorectal cancer is relatively
low at 8.5%, studies suggest a rise in rectal
cancer mortality due to increasing rates of latestage discovery of the disease [1,2]. Because
rectal cancers are often discovered at these later
stages where more extra-rectal tissue is
encompassed in the PTV, reducing toxicity to
surrounding organs is a primary objective of any
rectal radiotherapy plan [3]. Due to these
overlapping volumes, IMRT is highly preferred
over traditional 3D conformal therapy
(3DCRT), and has been shown to provide
significant clinical advantages with reduced
organ at risk (OAR) dose [4].
While the malleable dose distributions
possible with IMRT planning has allowed for
more personalized treatment plans as compared
to 3DCRT, it has also resulted in greater userdependency and quality variance across clinics
[5,6]. In addition to beam angle and isocenter
location, dosimetrists must also account for
placement and prioritization of optimization
goals, a task which relies heavily on the user’s
level of experience. More practiced planners
can know what DVH they can reasonably
achieve from a given patient geometry, whereas
others may not reach the most desirable solution
within the clinical timeframe. This uncertainty
in treatment planning, paired with the lack of
QA checks on plan optimality, results in an
unnecessary increase of patient risk and normal
tissue complications [7]. Thus, there is a need
for technologies that can not only reduce plan
quality variability, but can also be easily
implemented in smaller clinics with potentially
less experienced staff.
Varian’s solution to this problem is
RapidPlan (Varian Medical Systems, Palo Alto,
USA), a knowledge based planning (KBP)
1

This paper discusses a rectal 6X IMRT
model trained on a library of high-quality plans
from RTOG 0822. The model was tested for
planning QA and DVH improvement using
plans enrolled in the clinical trial.

resulting in a large, high-dimensional dataset
that cannot be effectively compressed without
losing significant data. However, this geometry
can be characterized by extracting the most
salient features using PCA. This effectively
reduces the dimensions of the data, allowing for
substantially fewer calculations and correlations
to relate patient geometries with dose
distributions.
Varian’s RapidPlan KBP software creates a
dose-to-target histogram (DTH) for each OAR
to use alongside PTV and OAR DVH’s during
PCA calculation. A DTH shows the fractional
overlap between an OAR and a virtual volume
symmetrically extended out from the PTV by a
given distance. A negative distance value
indicates OAR/PTV overlap, and this overlap
approaches 100% at an increased PTV
expansion distance, as seen in Figure 1.

2 Theory
2.1 Knowledge Based Planning
While the software behind it is moderately
complex, KBP is designed to behave very much
like a human treatment planner. A collection of
plans is submitted to the KBP as learning
material, with DVH’s the user has defined as
optimal and should be replicated. From these
high-quality plans, the KBP correlates
geometric features with attainable dose
distributions, and can predict an optimal dose
distribution for a new patient geometry. In this
way, the KBP acts as an automatic, easily
understood second check on inverse planning
optimization, allowing the user to see another
optimization route or possibilities for further
plan quality improvement. Similarly, KBP can
be used as a first step in creating a clinically
viable plan or evaluating the differences
between gantry angle combinations with little
effort needed. Indeed, KBP can be used to great
effect in clinics that want or need that extra bit
of manpower when it comes to creating or
verifying treatment plans.
This study specifically uses the Varian
RapidPlan KBP program, available in Eclipse
version 13.6.5. RapidPlan utilizes PCA to
identify the most important geometric features
for quick DVH correlation and estimation.

Figure 1: Sample DTH graphic from Zhu et al [8]

For each OAR and the m number of plans
within the learning library, the DVH and DTH
is sampled m times to creates a m-dimensional
component vector known as a feature point. In
many studies that aim to develop KBP’s, such
as Zhu et al [8], an m = 50 is used. A component
vector for each plan populates an n dimensional
feature space specific for each OAR. The
coordinate system of the feature space is shifted
such that the coordinate origin represents the

2.2 Principal Component Analysis
Correlating a patient-gantry geometry with a
three-dimensional dose distribution poses a
multitude of challenges. These geometries tend
to be highly complex, unique to the given
patient, and maintain a high voxel resolution,
2

average feature value, and points within the
space represent deviation from the mean. These
feature points are also normalized such that the
standard deviation of point distance about the
mean equals 1. A m x m covariance matrix of
these n points in this new coordinate system is
then created, and singular value decomposition
is performed to yield m eigenvectors and
eigenvalues. These eigenvectors form a PC
coordinate system that identifies the principal
components (PC’s), where the corresponding
eigenvalues represent the amount of variation in
a given component.
Thus, the principal
components can be chosen for use in model
training based on their variation, where
components with larger variations in DVH and
DTH yield more significant geometric data.
This sophisticated feature selection among the
m dimensional data allows for simplified data
representation with significant reduction of
calculation overhead [13].
Upon identification of the principal
components representing the dosimetry and
geometric data, SVR is used to map the
correlations and allow for DVH estimation. A
patient DVH can be predicted by extracting the
principal components from an input geometry
and applying the inverse rotation and translation
to this space to revert back to the original feature
space which constructed the correlation map
[8].

the segmented and assigned OAR’s. The center
of the band represents the median EDVH, and
the band stretches out one deviation away from
this median. For OAR’s, a two-dimensional
line exists within the bottom half of this band as
a continuous optimization line objective. As
seen in Figure 2, this provides a useful visual
marker for users to understand what OAR
sparing they can expect from a given plan before
any IMRT optimization takes place.

Figure 2: DVH, EDVH, and optimization line for rectal
IMRT optimized within RapidPlan during IMRT
optimization. The organs shown in this figure are the
PTV (blue), bladder (yellow), small bowel (brown), left
femoral head (purple), and right femoral head (green).

2.3 RapidPlan

Along with showing what the user can
expect out of a given plan, visualizing the
EDVH’s can also alert the user to the limitations
of a plan created in RapidPlan. Since the EDVH
designates what is expected based on
correlations formed from the learning library,
the plans and geometries submitted to the
library have a lasting effect on the model’s
effectiveness. If a model’s library largely
consists of plans with little PTV/OAR overlap,
then the model will not explicitly know how to
account for geometries with significant
PTV/OAR overlap, and will produce an

Varian RapidPlan offers a user-friendly KBP
platform that consistently estimates highquality treatment plans. Models created in
RapidPlan are modality and site specific,
performing best if they have a large library of
plans with similar OAR sets. Salient geometric
features are extracted for each plan in the library
using PCA and correlation with dosimetric
features via SVR.
When RapidPlan uses these correlations to
predict the dose distributions for a new plan,
estimated DVH (EDVH) bands are created for
3

undesired EDVH. During dose estimation, this
is often visualized for the user via warning
messages, very thin EDVH bands, or jagged
optimization objective lines.
Thus, it is
important to include a variety of patient
geometries within the training library to ensure
a wide coverage of patient anatomy and avoid
model overtraining for specific geometries.
RapidPlan has a variety of built-in tools to
assist users in understanding the statistics and
possible limitations of a given model. Within
the RapidPlan module built into Aria, users can
view a summary of training results with
goodness of correlation results and outlier
statistics, as well as organ-specific plots of
DVH’s, geometric statistics, DVH-geometric
correlation regressions, and EDVH-DVH
residual plots (where linearity indicates good
dosimetric estimation and successful model
training).
Using these tools, users can readily
determine issues with the model as a whole, as
well as with a particular submitted plan. If a
user finds that the EDVH consistently
underperforms for a given DVH region, they
can put in a manual point optimization
objective, similar to standard IMRT planning.
This will be used in the model alongside the
EDVH. The user can either manually set the
priority of the point objective or allow the
model to estimate its priority for a given patient
geometry.

Figure 3: Femoral heads regression plot for RapidPlan
model created in this paper

3 Method
3.1 Dosimetric Analysis of RTOG 0822
Plan Library
6X IMRT plans submitted to the RTOG 0822
clinical trial were evaluated for plan quality
before being used to create the initial iteration
of the model described in this paper. Plan
quality was determined by DVH adherence to
the target criteria specified in the RTOG
protocol. The radiation treatment criteria of a
national trial, such as the RTOG, consists of
dosimetric target parameters for both the target
and relevant OAR’s. The RTOG 0822 target
criteria specified that the IMRT dose must meet
a minimum PTV dose alongside maximum dose
constraints for the bladder, femoral heads, small
bowel, and PTV. Along with target criteria,
acceptable variation criteria is described to
allow for slight deviation in parameter
compliance and plan quality. These criteria sets
are tabulated in Table 1.
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Table 1: IMRT DVH target and acceptable variation parameters for the RTOG 0822 clinical trial

Minimum Dose Thresholds
Structure
Criteria Volume (%) Target Dose (Gy) Acceptable Dose (Gy)
PTV
98
41.85
40.5
Maximum Dose Thresholds
Structure
Criteria Dose (Gy)
Target Volume
Acceptable Volume
PTV
47.25
10%
15%
49.50
5%
10%
51.75
0%
N/A
Bladder
40
40%
55%
45
15%
30%
50
0%
0%
Femoral Heads
40
45%
65%
45
25%
40%
50
0%
0%
Small Bowel
35
180 cc
230 cc
40
100 cc
130 cc
45
65 cc
90 cc
Plans enrolled in the clinical trial were
anonymously stored on the American
College of Radiology (ACR) database and
accessed through remote access to the
Philadelphia server. From this server, plan
DVH’s were manually analyzed within the
MIM (MIMsoftware Inc, Cleveland, OH
44122) workspace and compared against the
RTOG 0822 criteria. These plans were then
imported from MIM into ACR’s Eclipse
platform and planned using the Eclipse CAP
– 6X Linac with Dose Dynamic MLC. Dose
estimation and IMRT optimization was
performed using the AAA_13714 and
PO_13714 models, respectively.
The
planning and dose optimization performed
in this study was used with these settings
and beam characteristics. Plans which met
the RTOG 0822 target criteria were labelled
as high-quality and used for initial training
of the model described in this paper, since
they are more likely to be associated with a
positive patient outcome [10].

5

3.2 RapidPlan Model Construction
and Optimization
Of the 97 IMRT plans were enrolled in the
RTOG 0822 clinical trial, 39 of them were
either not treated with 6X photons or could
not be imported into Aria, and thus were not
included in the 6X IMRT rectal model
created in this paper. Of the remaining 58
treatment plans, 26 met all of the target
criteria, and were thus considered highquality plans. Each of these plans met the
protocol’s prescribed 45 Gy to the rectal
target without the need of scaling or
normalization. These 26 plans were used to
create the initial iteration of the rectal model
described in this paper. While this count
met the 20 required plans to create a
RapidPlan model and provide a good
amount of geometry variance, an effort was
made to increase the number of plans in the
model’s training library while still adhering
to the target compliance metric.
Upon every new trained iteration of the
model, all of the 6X IMRT plans enrolled in

Equation 1: Quantitative difference in plan quality
weighted by RTOG criteria proximity

the clinical trial were reoptimized by the
newly trained model. This included both the
low-quality plans which did not meet the
target criteria as well as the high-quality
plans used to initially train the model. Since
most of the low-quality plans met the
acceptable variation criteria, an additional
12 geometries were able to be re-optimized
to reach high-quality, greatly increasing the
distribution of geometries in the training
library. If a high-quality plan was improved
via this cyclical re-optimization, the modelcreated plan was submitted to the model’s
training library alongside the initial enrolled
IMRT plan. If a subsequent re-optimization
resulted in a higher plan quality than the
previous re-optimization plan for a given
geometry, the lower-quality plan would be
replaced in the training pool.
If both the newly iterated and previous
DVH’s met RTOG target criteria, the
significant differences in plan quality
between them was evaluated by a net
summation of normalized dosimetric
differences, as described by Equation 1.
Dose differences were calculated at each
criteria volume mark and converted to a
ratio by diving by the average dose between
the two plans and the given volume mark’s
target dose, as listed in Table 1. As seen, the
closer a dose point change is to the target
criteria, the more weighted the ratio. These
normalized ratios are summed together, to
give a simplified evaluation of if plan
quality increased in reference to the RTOG
criteria, with a positive summation
suggesting plan quality increase, and a
negative summation suggesting plan quality
decrease. PTV dose homogeneity, dose
conformity, isodose curves, and normal
tissue dose were also qualitatively evaluated
to ensure plan quality. If there was no
significant plan quality increase, the
previous plan was not replaced.

𝑁𝑂𝑟𝑔

𝑁𝑐𝑟𝑖𝑡

𝑖

𝑄𝐷𝑖𝑓𝑓 = ∑ ( ∑ 𝑍𝑖𝑗 ) + 𝑍𝑃𝑇𝑉𝑈𝑝𝑝𝑒𝑟
𝑖=1

𝑍𝑖𝑗 =

𝑗=1

𝐷𝑃𝑟𝑒𝑣𝑖𝑗 − 𝐷𝑁𝑒𝑤𝑖𝑗
𝐷𝑃𝑟𝑒𝑣 𝑖𝑗 + 𝐷𝑁𝑒𝑤 𝑖𝑗
|
− 𝐷𝑐𝑟𝑖𝑡𝑒𝑟𝑖𝑎𝑖𝑗 |
2

𝑍𝑃𝑇𝑉𝑈𝑝𝑝𝑒𝑟 =

𝐷98𝑁𝑒𝑤 − 𝐷98𝑃𝑟𝑒𝑣
𝐷98𝑃𝑟𝑒𝑣 + 𝐷98𝑁𝑒𝑤
|
| − 45 𝐺𝑦
2

This process was cyclically repeated for
every new instance of the model until an
equilibrium of re-optimized plan quality
was reached.

3.3 Model Inputs
Along with training from the clinical plans
submitted to the RTOG clinical trial, the
model was also trained and optimized using
a set of manual dosimetric optimization
goals. This was to focus optimization and
plan quality improvements on the RTOG
target criteria, increasing the number of
geometries used in model training. For
OAR dose sparing constraints, optimization
goals were set at the target criteria volumes
at 5 Gy below the target criteria dose to tend
the resulting dose below the target
thresholds. Priority for these manual OAR
constraints was determined by the model
alongside the continuous optimization
objective. It should be noted that these OAR
point objectives did not impact the result
IMRT DVH nearly as significantly as the
continuous
optimization
objectives
produced by RapidPlan.
While RapidPlan can also create
continuous optimization objectives for the
PTV, this was found to produce variable to
non-desirable results. To mitigate PTV dose
coverage variation, manual optimization
objectives with set priorities were
6

implemented for the PTV. These objectives
ensured that plans both met RTOG target
criteria and resulted in conformality index
values approximately equal to 1. Normal
tissue sparing was also manually set to
produce consistently good dose falloff from
the PTV and eliminate dose hotspots outside
of the PTV.

target and acceptable variation criteria,
raising this number from 9 to 10. This
suggests that the model was successful in
increasing the plan quality of low-quality
rectal IMRT plans.

4.1 Model Training
The model was able to be successfully
trained and raised to an equilibrium of
quality through iterative reoptimization
using both enrolled and reoptimized highquality plans.
A total of 40 patient
geometries were used in model training.
The model was trained to estimate dose for
the OAR’s specified by RTOG 0822, as well
as the individual femoral heads. This was to
ensure that one of the femoral heads was not
getting a significantly higher dose than the
other, a piece of data otherwise lost when
evaluated as a single structure. The results
of this training are shown in Table 2.
As seen, the training successfully
correlated the principle components of all
the OAR’s used in training. It should be
noted that while the bladder was
successfully trained, as seen in the very
good χ2 value, a significant PTV/bladder
overlap variability among the patient
geometries resulting in a lower R2 value for
principal component correlation. While this
produced slight EDVH issues towards
higher dose regions, as seen in Figure 2,
negligible estimated dose errors were
observed for the patient geometries
evaluated in this study.

3.4 Model QA Validation
Dosimetric analysis was performed to
quantify the effects of re-optimization on
plan quality, and thus patient outcome. Plan
quality was determined using Equation 1
with the RTOG 0822 target criteria
described in Table 1. This was performed
for and summed over every OAR and PTV
target criteria for a given patient, with a
positive value indicating an increase in plan
quality and a negative value indicating a
decrease. Dose homogeneity, isodose curve
geometry, and normal tissue sparing were
qualitatively judged
alongside
this
quantitative metric if a plan iteration was of
approximately equal quantitative quality as
its previous iteration.

4 Results and Discussion
The results of the dosimetric analysis of
both the plans enrolled into RTOG 0822 and
the plans reoptimized by the model
discussed in this paper are listed in Table 3.
This shows the number of plans from each
set that met the RTOG target criteria, the
acceptable variation criteria, and neither
criteria (resulting in a failure). As seen, the
dose estimation model significantly
increased the number of plans which met the
target criteria, raising it from 26 of the
enrolled plans to 39 of the reoptimized
plans. However, it should be noted that
model reoptimization also slightly increased
the number of plans which failed both the

Table 2: Model Training Statistics

Organ
Bladder
Small Bowel
Femoral Heads
Femoral Head
[L]
Femoral Head
[R]
7

Trained
Yes
Yes
Yes
Yes
Yes

R2
0.517
0.835
0.701
0.688

χ2
1.101
1.132
1.090
1.074

0.676 1.069

4.2 Model
Validation

Optimization

and

Results of model reoptimization are shown
below in Table 3. As seen, there is a
significant increase in the number of plans
which met target criteria as compared to the
original plans enrolled in RTOG 0822. It
should be noted that one of the enrolled 6X
IMRT plans could not be reoptimized in
RapidPlan due to software issues. While
this plan was not included in the statistics
for the enrolled plan quality count,
reoptimization plan count, and model
validation evaluation.
For the reoptimized plans, the
performance per organ is listed below in
Table 4 and 5. As seen, the RapidPlan
model consistently met the RTOG OAR and
PTV criteria, raising many of the organs up
to either target or acceptable variation
criteria. This improvement occurred for all
of the OAR’s specified in RTOG 0822
except for the femoral heads, which were
always within the RTOG target constraints
for both the enrolled and reoptimized plans.

Figure 4: Geometric plots of the bladders used in
model training (upper) and the principal component
estimation residual plot (lower)

Table 3: Count of plans that met RTOG 0822 criteria

RTOG 0822 Criteria Enrolled Plans Reoptimized Plans Quality Count Diff
Target
26 (44.8%)
39 (67.2%)
+13 (+22.4%)
Acceptable
23 (39.7%)
9 (15.5%)
-14 (-24.1%)
Failed
9 (15.5%)
10 (17.2%)
+1 (+1.7%)
Table 4: Number of reoptimized plans which met quality per organ

Criteria
PTV
Bladder
Femoral Heads Small Bowel
Target
50 (86.2%) 49 (84.5%)
58 (100%)
53 (91.4%)
Acceptable
0 (0%)
6 (10.3%)
0 (0%)
5 (5.2%)
Fail
8 (14%)
3 (5.2%)
0 (0%)
0 (0%)
Table 5: Organs where model reoptimization caused plan quality changes

Organ

Raised to Raised to Reduced to Reduced to Net Quality
Target Acceptable Acceptable
Fail
Increase
PTV
7
1
0
7
+1 (+1.7%)
Bladder
11
0
2
2
+7 (+12.1%)
Femoral Heads
0
0
0
0
0 (+0%)
Small Bowel
4
1
0
1
+2 (+3.4%)
8

For cases where the RTOG constraint on the
PTV was broken, this failure was often due to
over-exposure in the PTV at 15% and 10%
volume in order to maintain a high dose at 98%
volume while preserving surrounding organs.
This is likely the result of placing manual
constraints on the PTV and not allowing the
model to directly change these optimization
goal priorities. In cases such as these, it is up to
the dosimetrist and physician to decide how
much they are willing to underdose the PTV or
further expose OAR’s. In cases where plan
quality was reduced due to OAR constraints
(either to acceptable variation criteria or
failure), this was often due to increased OAR
dose to maintain homogenous dose over the
PTV. While this is labeled a reduction in plan
quality by the metric used in this paper, this risk
tradeoff between the PTV and OAR’s should be
evaluated on a patient-by-patient basis during
treatment planning. Below, Figure 5 shows an
example of the model improving a low quality
DVH to high quality.

5 Conclusion
A KBP model was developed using Varian’s
RapidPlan software platform and designed for
dose estimation of locally advanced rectal
tumors treated with 6X IMRT. The model
described in this paper was initially created
using 26 high-quality 6X plans enrolled in the
RTOG 0822 clinical trial. Additional plans
among the enrolled RTOG plans were raised to
high-quality through model-based iterative
reoptimization and implementation into the
model’s training library until an equilibrium of
model-produced plan quality was achieved.
Through this iterative method, an additional 12
geometries were available for the model to use
in EDVH training.
Applying model reoptimization to the plans
enrolled in the RTOG exhibited a 22.4%
increase in the number of plans that met target
criteria. Specifically, the model exhibited
significant dose sparing to the bladder and small
bowel. However, the model was shown to
exhibit overexposure in the PTV in cases of
difficult OAR sparing, albeit for a minority of
cases. While the ability to produce a highquality plan can vary from patient to patient, the
model introduced in this paper has been shown
to consistently produce a plan of equal or greater
quality than the RTOG-enrolled plan, and can
be used as an effective tool for planning QA of
rectal IMRT cases.

Figure 5: Comparison of original enrolled plan DVH
(squares) against the reoptimized plan DVH (triangles).
The organs shown in this figure are the PTV (pink),
bladder (yellow [right pair]), small bowel (blue), and
femoral heads (yellow [left pair]).
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